Sponsor:
National Institutes of Health
UI Contact:
Updated Date:
Sep 17, 2019
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Policy Notices
- Reminder - NIH Natural Disaster Policy - Hurricane Dorian
National Institutes of Health
General Notices
- Notice of Pre-Application Webinar for FOAs related to the NHLBI CATALYZE Program: RFA-HL-20-022, RFA-HL-20-023, RFA-HL-20-024, RFA-HL-20-027 and RFA-HL-20-028
National Heart, Lung, and Blood Institute
- AHRQ Encourages Use of Fast Healthcare Interoperability Resources (FHIR) Standard
Agency for Healthcare Research and Quality
- HEAL/NINDS Early Phase Pain Investigation Clinical Network (EPPIC-Net): Opening to applications for non-addictive pain therapeutics
National Institute of Neurological Disorders and Stroke
- New to Working with the NIH Grants Process & Policies? Don’t Miss the NIH Regional Seminar on Program Funding and Grants Administration Phoenix, AZ Nov. 6-8, 2019
National Institutes of Health
- Request for Information (RFI) on the Lessons Learned from the Accelerating Medicines Partnership Rheumatoid Arthritis and Lupus (AMP RA/SLE Program)
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- Request for Information (RFI): Inviting comments and suggestions on the development of a prize competition for Gender Diversity in the Biomedical Research Workforce
Office of Research on Women's Health
- Request for Information (RFI): Enhancing the Clinical and Translational Science Awards (CTSA) Program
National Center for Advancing Translational Sciences
Notice of Changes to Funding Opportunities
- NIDDK Notice of Participation in PA-19-273, "PHS 2019-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)"
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Clarification of Eligible Individuals for RFA-DK-18-024 "Predoctoral to Postdoctoral Fellow Transition Award (F99/K00)"
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of Clarification of Research Strategy for RFA-DK-19-010 Polycystic Kidney Disease (PKD) Research and Translation Core Centers"
National Institute of Diabetes and Digestive and Kidney Diseases
- Notice of NIBIB's Participation in PAR-19-343 "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
National Institute of Biomedical Imaging and Bioengineering
- Notice of Change of Receipt Date for RFA-HD-20-007 "The Role of Stem/Progenitor Cells in the Pathogenesis and Treatment of Gynecologic Disorders (R21 Clinical Trial Optional)"
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Notices of Intent to Publish
- Notice of Intent to Publish a Funding Opportunity Announcement for Early Liver Transplantation Cohort Study (U10 - Clinical Trial Optional)
National Institute on Alcohol Abuse and Alcoholism
Notices of Special Interest
- Notice of Special Interest in High Priority Research Areas for Sex and Gender Influences on the Adolescent Brain and the Mental Health of Girls and Young Women (Ages 12-24)
National Institute of Mental Health
Funding Opportunities
- Limited Competition: Small Grant Program for NIDDK K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
National Institute of Diabetes and Digestive and Kidney Diseases
- Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
National Institute of General Medical Sciences
- Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)
National Institute on Drug Abuse
National Institute on Alcohol Abuse and Alcoholism
- Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
- NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
- NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
- Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed)
National Institute on Minority Health and Health Disparities
National Human Genome Research Institute
National Institute on Aging
- Complex Integrated Multi-Component Projects in Aging Research (U19 Clinical Trial Optional)
National Institute on Aging
- Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Cancer Institute
National Heart, Lung, and Blood Institute
National Institute on Alcohol Abuse and Alcoholism
National Institute of Dental and Craniofacial Research
- Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
John E. Fogarty International Center
National Cancer Institute
National Institute of Biomedical Imaging and Bioengineering
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Office of Behavioral and Social Science Research
Office of Research on Women's Health
- Omics-guided Biobehavioral Interventions for Improved Health Outcomes: A Step Forward in Translation (R01 Clinical Trial Optional)
National Institute of Nursing Research
- MD-PhD Training Program in Alzheimer's Disease and Related Dementias and the Behavioral and Social Sciences (T32 Clinical Trial Not Allowed)
National Institute on Aging
- Tailoring Interventions to Improve Preventive Health Service Use (R61/R33 Clinical Trial Required)
National Institute on Aging
Office of Disease Prevention
- Advancing Sustained/Extended Release for HIV Prevention (A-SER) (R01 Clinical Trial Not Allowed)
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
- Informatics Technology for Cancer Research Education Center (UE5 Clinical Trials Not Allowed)
National Cancer Institute
- Improving the Reach and Quality of Cancer Care in Rural Populations (R01 Clinical Trial Required)
National Cancer Institute
- The Rat Opioid Genome Project: Clinical Trials not Allowed (U01- Clinical Trial Not Allowed)
National Institute on Drug Abuse
- NIDDK Cooperative Centers of Excellence in Hematology (U54 Clinical Trial Not Allowed)
National Institute of Diabetes and Digestive and Kidney Diseases
- Data Sharing for Demographic Research Infrastructure Program (R24 Clinical Trial Not Allowed)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Fertility and Fertility Preservation for Patients with Diseases that Previously Precluded Reproduction (R21 Clinical Trial Optional)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
National Cancer Institute
National Institute on Aging
National Institute of Allergy and Infectious Diseases
- Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
National Heart, Lung, and Blood Institute
- Catalyze: Product Definition for Small Molecules and Biologics - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
- Catalyze: Product Definition for Small Molecules and Biologics - Preliminary Product/Lead Series Identification (R33 - Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
- Catalyze: Product Definition Device Prototype Testing and Design Modification, Diagnostic Disease Target Assay Development and Design Characterization, and Research Tool Testing and Validation (R33 - Clinical Trials Not Allowed)
- Catalyze: Product Definition Device Prototype Design and Testing, Diagnostic Disease Target Identification and Assay Development, and Research Tool Development (R61/R33 - Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
- Bench to Bassinet Program Administrative Coordinating Center (U01 - Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute
- Resource-Related Research Projects for Development of Animal Models and Related Materials (R24 Clinical Trials Not-Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at dsp@uiowa.edu or 335-2123, or email Lynn Hudachek at lynn-hudachek @uiowa.edu